Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant

Author： Ciulla Thomas A   Harris Alon   McIntyre Nathaniel   Jonescu-Cuypers Christian  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.7, 2014-05, pp. : 953-959

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema

By Yilmaz Taygan   Cordero-Coma Miguel   Federici Thomas J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1327-1335

Informa Healthcare

Access to resources Recommend Favorite

Fluocinolone Acetonide Ophthalmic – Bausch & Lomb: Fluocinolone Acetonide Envision TD Implant

By Adis International Limited  

Drugs in R&D, Vol. 6, Iss. 2, 2005-01 ,pp. : 116-119

Adis International

Access to resources Recommend Favorite

NICE says "no" to pirfenidone and fluocinolone acetonide implant

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 668, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration

By  

Current Drug Targets, Vol. 12, Iss. 2, 2011-02 ,pp. : 149-172

Bentham Science Publishers

Access to resources Recommend Favorite

Fluocinolone Acetonide Implantable Device for Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-03 ,pp. : 347-351

Bentham Science Publishers

Access to resources Recommend Favorite